thymosin alpha 1 comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.
Laboratory work indicates that the peptide acts on cells of both the innate and adaptive immune systems. Reported effects include signalling through Toll-like receptors on dendritic cells, enhanced T-cell maturation, and increased natural killer cell activity. These actions are described largely from cell-culture and animal experiments, and the precise receptor-level events remain incompletely defined. Studies in humans have generally measured immune markers rather than a single defined molecular target. The resulting picture remains partly descriptive.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Results across trials have been mixed, and several studies were small or conducted under differing protocols. Regulatory status varies by country, and the compound is not approved in every jurisdiction where it is studied. Evidence for any single indication should be read with attention to sample size and endpoint choice.
市售的胸腺素α1通常以冻干粉形式提供，溶解后用于注射。其氨基酸组成包括多个酸性残基，因此在中性pH下带负电荷。该肽可溶于水和生理盐水，但在有机溶剂中溶解度有限。储存条件通常为冻干状态下负20摄氏度，溶解后需冷藏并避免反复冻融。常见的同义词包括胸腺肽α1、thymalfasin和Tα1。
胸腺素α1（thymosin alpha 1，Tα1）是一种由28个氨基酸组成的酸性肽，N端被乙酰化，分子量约为3108道尔顿。该肽最早从牛胸腺组织提取物中分离，属于胸腺素组分5的一个成分。其序列在不同哺乳动物中高度保守，提示其具有基本的生物学功能。名称中的“α1”指其在电泳中的迁移位置，并非表示亚型编号。它既存在于胸腺，也存在于脾脏和淋巴结等免疫组织。
20世纪70年代，研究者从胸腺提取物中纯化出多种小肽，Tα1是其中被较早表征的一种。最初的制备依赖组织匀浆和层析步骤，产量低且成分复杂。随着固相肽合成技术成熟，实验室和工业界能够生产与天然序列一致的合成版本。合成肽的纯度可达95%以上，并可通过反相高效液相色谱和质谱进行鉴定。这一转变使研究不再依赖动物胸腺来源。
| Property | Value | Notes |
|---|---|---|
| Chemical class | Peptide | 28 amino acid residues |
| Molecular weight | Approximately 3108 Da | Depends on acetylation state |
| N-terminal modification | Acetylated | Affects charge and stability |
| Natural source | Fragment of thymosin beta-4 | Cleaved in vivo |
| Sequence length | 28 residues | Synthetic form matches natural |
Biologically, the peptide is studied mainly in the context of immune cell development and regulation. It is produced in the thymus and in several other tissues, and it appears to influence the maturation and activity of T cells and other immune populations. Laboratory work describes effects on cytokine production, on the balance between T cell subsets, and on the function of dendritic cells. Much of this evidence comes from cell culture and animal models, so the extent to which the same pathways operate in humans remains an open question.
Clinical interest has centered on chronic viral hepatitis, on immune restoration in various conditions, and on use as an adjuvant intended to improve responses to vaccines. Trials have reported mixed results, and regulatory status differs sharply between countries; in some places it is a prescription product, while elsewhere it is sold without an approved therapeutic indication. Because published studies vary widely in design, population, and endpoints, comparisons across them are difficult and no single conclusion covers the whole literature.
Immunological studies connect the peptide to multiple parts of the immune response. It has been reported to engage Toll-like receptor signaling, to promote dendritic cell maturation, and to influence the balance of T helper cell subsets. Changes in natural killer cell activity and in cytokine release appear in cell culture and animal models. These observations describe broad immunomodulatory behavior rather than a single defined receptor target, and the primary molecular interaction has not been settled.
Thymosin alpha-1 is a synthetic 28-amino-acid peptide whose sequence was first identified in extracts of bovine thymus tissue during the 1970s. The chain carries an acetyl group on its N-terminal serine. Its acidic residue content is high, which produces strong water solubility and an isoelectric point well below neutrality. Material supplied for laboratory and clinical use is manufactured by solid-phase peptide synthesis rather than purified from animal tissue. Different salt forms, such as the acetate, alter the counter-ion content without changing the peptide backbone.
==== MeSH E05.601.495 – immunoassay ==== MeSH E05.601.495.320 – immunoblotting MeSH E05.601.495.320.200 – blotting, western MeSH E05.601.495.350 – immunoenzyme techniques MeSH E05.601.495.350.170 – enzyme-linked immunosorbent assay MeSH E05.601.495.350.180 – enzyme multiplied immunoassay technique MeSH E05.601.495.380 – immunosorbent techniques MeSH E05.601.495.380.360 – enzyme-linked immunosorbent assay MeSH E05.601.495.380.810 – radioallergosorbent test MeSH E05.601.495.380.825 – radioimmunoprecipitation assay MeSH E05.601.495.380.830 – radioimmunosorbent test MeSH E05.601.495.639 – radioimmunoassay MeSH E05.601.495.639.405 – immunoradiometric assay MeSH E05.601.495.639.810 – radioallergosorbent test MeSH E05.601.495.639.825 – radioimmunoprecipitation assay MeSH E05.601.495.639.830 – radioimmunosorbent test
==== Interactions with other nephrotoxins ==== Another area of controversy and uncertainty is whether and to what extent vancomycin increases the toxicity of other nephrotoxins. Clinical studies have yielded various results, but animal models indicate that the nephrotoxic effect probably increases when vancomycin is added to nephrotoxins such as aminoglycosides. A dose- or serum level-effect relationship has not been established.
=== Polymorphisms === Single nucleotide polymorphisms (SNPs) genetic variations within OPRK1, have been associated with susceptibility to substance use disorders and stress-related behaviors. The G36T SNP (rs1051660) is more frequent in heroin-dependent individuals compared to healthy controls. Other study found an association of OPRK1 variants with cocaine dependence and relapse susceptibility.
Increased probability of cell mutation (carcinogenic activity) A multitude of simultaneous assorted actions which may be deleterious Interaction (additive, multiplicative, or metabolic) Induced physiological damage, or abnormal chronic conditions Overstimulation or Inhibition of receptors- lead to harmful physiological changes Development of tolerance - reduce their responsiveness, requiring higher doses of drug. Induced pathological conditions - long term structural or functional changes Disturbed homeostasis Functional selectivity (biased Agonism) - preferentially activate certain pathways over others, potentially leading to off-target or unanticipated effects.
Animation – Ratchet & Clank: Rift Apart Artistic Achievement – The Artful Escape Audio Achievement – Returnal Best Game – Returnal British Game – Forza Horizon 5 Debut Game – TOEM EE Game of the Year – Unpacking Evolving Game – No Man's Sky Family – Chicory: A Colorful Tale Game Beyond Entertainment – Before Your Eyes Game Design – Inscryption Multiplayer – It Takes Two Music – Returnal Narrative – Unpacking Original Property – It Takes Two Performer in a Leading Role – Jane Perry as Selene Vassos in Returnal Performer in a Supporting Role – Kimberly Brooks as Hollis Forsythe in Psychonauts 2 Technical Achievement – Ratchet & Clank: Rift Apart
Sources: en.wikipedia.org
Hawaiian–Emperor seamount chain (Hawaii hotspot) Louisville Ridge (Louisville hotspot) Walvis Ridge (Gough and Tristan hotspot) Kodiak–Bowie Seamount chain (Bowie hotspot) Cobb–Eickelberg Seamount chain (Cobb hotspot) New England Seamounts (New England hotspot) Anahim Volcanic Belt (Anahim hotspot) Mackenzie dike swarm (Mackenzie hotspot) Great Meteor hotspot track (New England hotspot) St. Helena Seamount Chain–Cameroon Volcanic Line (Saint Helena hotspot) Southern Mascarene Plateau–Chagos-Maldives-Laccadive Ridge (Réunion hotspot) Ninety East Ridge (Kerguelen hotspot) Tuamotu–Line Island chain (Easter hotspot) Austral–Gilbert–Marshall chain (Macdonald hotspot) Juan Fernández Ridge (Juan Fernández hotspot) Tasmantid Seamount Chain (Tasmantid hotspot) Canary Islands (Canary hotspot) Cape Verde (Cape Verde hotspot)
Monoclonal antibodies (mAbs) have varied therapeutic uses. It is possible to create a mAb that binds specifically to almost any extracellular target, such as cell surface proteins and cytokines. They can be used to render their target ineffective (e.g. by preventing receptor binding), to induce a specific cell signal (by activating receptors), to cause the immune system to attack specific cells, or to bring a drug to a specific cell type (such as with radioimmunotherapy which delivers cytotoxic radiation). Major applications include cancer, autoimmune diseases, asthma, organ transplants, blood clot prevention, and certain infections.
For example, the nitrile group of the competitive PDE-3 inhibitor milrinone forms an affinity-relevant hydrogen bond via a histidine residue located at the binding site of these phosphodiesterases. Nitriles can form a coordinative bond with calcium cations, which is essential for the activity of calcium antagonists of the verapamil type. These agents inhibit calcium influx by forming, through ligand–calcium complex chemistry, a salt bridge with one of the glutamic acid residues in the selectivity filter within the pore of the calcium channel. Verapamil is used in cardiovascular diseases such as arterial hypertension and angina pectoris. Nitrile substituents decrease the electron density of aromatic compounds through a strong inductive effect. In this manner, π-π interactions between a drug molecule and suitable amino acid residues of a target protein, such as phenylalanine, tyrosine, tryptophan, and histidine, are modulated. Such π-π interactions are observed with the aromatase inhibitors letrozole and anastrozole, which act as antiestrogens and are used in breast cancer. Many androgen receptor antagonists contain a markedly electron-deficient aromatic ring, which is particularly important for supramolecular receptor binding. In bicalutamide, enzalutamide, and other analogs used to treat prostate cancer, a nitrile group contributes to this electronic effect. In some cases, nitriles form a reversible yet pharmacologically relevant covalent bond with a target molecule.
== Affected areas == Many states are directly affected by the drug trade that occurs in the Indian Ocean region, both economically and socially. These detrimental effects are felt throughout many different countries, in a variety of ways, such as a possible increase in drug use by the populations and heightened levels of corruption.
Sources: en.wikipedia.org
== Career == Balalaie joined the faculty of K. N. Toosi University of Technology as an Assistant Professor (1997-2003), was promoted to Associate Professor (2003-2007), and has served as a Full Professor since 2007. Throughout his career, he has maintained research collaborations with German institutions through multiple Alexander von Humboldt Foundation fellowships, beginning in 2002. His collaborations include work at Heidelberg University, University of Freiburg, Heinrich Heine University Düsseldorf, and the University of Duisburg-Essen. From 2015 to 2020, he served as the Scientific Ambassador of the Alexander von Humboldt Foundation in Iran, facilitating scientific cooperation between Iranian and German researchers.
==== Metabolism ==== Sertraline is subject to extensive first-pass metabolism, as indicated by a small study of radiolabeled sertraline in which less than 5% of plasma radioactivity was unchanged sertraline in two males. The principal metabolic pathway for sertraline is N-demethylation into desmethylsertraline (N-desmethylsertraline) mainly by CYP2B6. Reduction, hydroxylation, and glucuronide conjugation of both sertraline and desmethylsertraline also occur. Desmethylsertraline, while pharmacologically active, is substantially (50-fold) weaker than sertraline as a serotonin reuptake inhibitor and its influence on the clinical effects of sertraline is thought to be negligible. Based on in vitro studies, sertraline is metabolized by multiple cytochrome 450 isoforms; however, it appears that in the human body CYP2C19 plays the most important role, followed by CYP2B6. In addition to the cytochrome P450 system, sertraline can be oxidatively deaminated in vitro by monoamine oxidases; however, this metabolic pathway has never been studied in vivo.
=== Congeners === Coronaridine congeners are important in drug discovery and development due to multiple actions on different targets. They have ability to inhibit Cav2.2 channel, modulate and inhibit subunits of nAChr selectively such as α9α10, α3β4 and potentiate GABAA activity.
This can be achieved because dimethyl fumarate and monomethyl fumarate, as cell-permeable metabolites, can epigenetically regulate the expression of micro-RNA-21 via the metabolic-epigenetic interplay in developing immune cells. The main activity of dimethyl fumarate and monomethyl fumarate is considered to be immunomodulatory, resulting in a shift in T helper cells (Th) from the Th1 and Th17 profile to a Th2 phenotype. Inflammatory cytokine production is reduced by the induction of proapoptotic events, inhibition of keratinocyte proliferation, reduced expression of adhesion molecules and diminished inflammatory infiltrate within psoriatic plaques. The primary route of elimination is via exhalation of CO2, with small amounts excreted through urine or faeces. There is no evidence for dimethyl fumarate interaction with cytochrome P450 and the most common efflux and uptake transporters, and therefore no interactions are expected with medicinal products metabolised or transported by these systems.
Mast cells are seen as "first responders" that deal with pathogens by alerting other immune cells and coordinating immune responses in the innate and acquired immune systems. When activated, a mast cell can either selectively release (piecemeal degranulation) or rapidly release (anaphylactic degranulation) compounds or mediators from storage granules into the local environment. In addition to the rapid release of pre-formed stored mediators, mast cells can also secrete newly synthesized mediators. The activation of mast cell receptors in specific signaling networks leads to the selective release of mediators that manage both local rapid reactions and long-term responses to stimuli. As part of a healthy immune system, mast cell mediators manage cycles of inflammation and repair, initially producing inflammation to counter harmful stimuli and later repairing damaged tissues to restore homeostasis. MCs play an important protective role in the defense and repair of cells through wound healing, angiogenesis, vascular permeability, and responses to bacteria, parasites, fungi, viruses and venoms. Dysfunction of mast cells is linked to a variety of diseases: MCs are best known for their roles in allergy, anaphylaxis, and eczema (atopic dermatitis).
Sources: en.wikipedia.org
It corresponds to the first 28 amino acids of thymosin beta-4, a larger protein found in many tissues. The fragment is acetylated at its N-terminus and is produced synthetically for research and pharmaceutical use. Synthetic and natural forms share the same sequence.
It is usually described as an immunomodulatory peptide rather than a classical hormone. It does not travel to a single distant organ in the manner of an endocrine hormone. Classification varies across sources, and some texts group it with thymic peptides generally.
The broad outline involves immune cell activation, but the specific molecular steps remain under investigation. Different studies report effects on dendritic cells, T cells, and natural killer cells. No single receptor has been confirmed as the sole mediator.
它不是经典的内分泌激素，而是一种免疫调节肽。其作用主要通过局部免疫细胞间的信号传递实现，而非经血液循环作用于远隔器官。